WallStreetZenWallStreetZen

NASDAQ: BPMC
Blueprint Medicines Corp Stock Ownership - Who owns Blueprint Medicines?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Blueprint Medicines Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ariel HurleyPRINCIPAL ACCOUNTING OFFICER2025-05-051,400$103.57
$145.00kSell
Christina RossiCHIEF OPERATING OFFICER2025-05-05144$103.56
$14.91kSell
Christina RossiCHIEF OPERATING OFFICER2025-05-05180$102.82
$18.51kSell
Christina RossiCHIEF OPERATING OFFICER2025-05-051,343$101.77
$136.68kSell
Christina RossiCHIEF OPERATING OFFICER2025-05-05607$100.97
$61.29kSell
Ariel HurleyPRINCIPAL ACCOUNTING OFFICER2025-05-051,252$102.51
$128.34kSell
Ariel HurleyPRINCIPAL ACCOUNTING OFFICER2025-05-052,752$54.13
$148.97kBuy
Ariel HurleyPRINCIPAL ACCOUNTING OFFICER2025-05-05100$104.78
$10.48kSell
Kate HavilandCHIEF EXECUTIVE OFFICER2025-04-01600$85.47
$51.28kSell
Kate HavilandCHIEF EXECUTIVE OFFICER2025-04-011,200$87.34
$104.81kSell

1 of 11

BPMC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BPMC insiders and whales buy or sell their stock.

BPMC Shareholders

What type of owners hold Blueprint Medicines Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc10.64%6,869,327$682.85MInstitution
Vanguard Group Inc10.49%6,774,884$673.46MInstitution
Price T Rowe Associates Inc8.79%5,679,089$564.53MInstitution
Kevin P. Starr8.44%5,453,753$542.13MInsider
Wellington Management Group LLP6.63%4,281,364$425.59MInstitution
Fmr LLC6.29%4,062,040$403.79MInsider
Mark J. Levin5.52%3,564,997$354.38MInsider
State Street Corp3.87%2,500,207$248.53MInstitution
Fmr LLC3.48%2,247,679$223.43MInstitution
William Blair Investment Management LLC3.01%1,944,695$193.31MInstitution

1 of 3

BPMC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BPMC82.35%17.65%Net SellingNet Selling
MDGL25.70%74.30%Net SellingNet Buying
BBIO60.06%39.94%Net SellingNet Selling
JAZZ27.90%72.10%Net SellingNet Buying
HALO78.13%21.87%Net SellingNet Selling
View Top Biotech Stocks

Blueprint Medicines Stock Ownership FAQ

Who owns Blueprint Medicines?

Blueprint Medicines (NASDAQ: BPMC) is owned by 104.15% institutional shareholders, 22.33% Blueprint Medicines insiders, and 0.00% retail investors. Kevin P. Starr is the largest individual Blueprint Medicines shareholder, owning 5.45M shares representing 8.44% of the company. Kevin P. Starr's Blueprint Medicines shares are currently valued at $531.80M.

If you're new to stock investing, here's how to buy Blueprint Medicines stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.